The Oncology Institute, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-19.2% -$767K
$3M
Free Cash Flow↓-3.2% -$72K
$2M
Investing Cash Flow↓-101.0% -$20M
$-202K
Financing Cash Flow
$4M
Capex↓-39.6% -$695K
$1M
Acquisitions
$0
Stock Buybacks
$0
Stock-Based Comp↑+2.2% +$28K
$1M
Debt Issued
—
Debt Repaid
$0
D&A↓-4.4% -$75K
$2M
SBC Allocated Expense↑+2.2% +$28K
$1M